Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine S Grasso

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Nature Biotechnology|August 2, 2011
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progressionJohn R Prensner, Matthew K Iyer, O Alejandro Balbin, et al.
Cancer Discovery|May 30, 2020
Overcoming Genetically Based Resistance Mechanisms to PD-1 BlockadeDavis Y Torrejon, Gabriel Abril-Rodriguez, Ameya S Champhekar, et al.
Nature Cancer|August 9, 2021
PAK4 inhibition improves PD-1 blockade immunotherapyGabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, et al.
Nature Medicine|November 22, 2011
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancerDan R Robinson, Shanker Kalyana-Sundaram, Yi-Mi Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancerXiaoyong Fu, Rinath Jeselsohn, Resel Pereira, et al.
Cancer Discovery|December 2, 2016
Primary Resistance to PD-1 Blockade Mediated by JAK1/2 MutationsDaniel Sanghoon Shin, Jesse M Zaretsky, Helena Escuin-Ordinas, et al.
Nature|June 23, 2012
The mutational landscape of lethal castration-resistant prostate cancerCatherine S Grasso, Yi-Mi Wu, Dan R Robinson, et al.
Oncotarget|November 23, 2017
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategyDaniel H Hovelson, Chia-Jen Liu, Yugang Wang, et al.
Neoplasia (New York, N.Y.)|May 1, 2015
Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumorsDaniel H Hovelson, Andrew S McDaniel, Andi K Cani, et al.
Cancer Cell|September 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Nature Biotechnology|August 2, 2011
Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progressionJohn R Prensner, Matthew K Iyer, O Alejandro Balbin, et al.
Cancer Discovery|May 30, 2020
Overcoming Genetically Based Resistance Mechanisms to PD-1 BlockadeDavis Y Torrejon, Gabriel Abril-Rodriguez, Ameya S Champhekar, et al.
Nature Cancer|August 9, 2021
PAK4 inhibition improves PD-1 blockade immunotherapyGabriel Abril-Rodriguez, Davis Y Torrejon, Wei Liu, et al.
Nature Medicine|November 22, 2011
Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancerDan R Robinson, Shanker Kalyana-Sundaram, Yi-Mi Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancerXiaoyong Fu, Rinath Jeselsohn, Resel Pereira, et al.
Cancer Discovery|December 2, 2016
Primary Resistance to PD-1 Blockade Mediated by JAK1/2 MutationsDaniel Sanghoon Shin, Jesse M Zaretsky, Helena Escuin-Ordinas, et al.
Nature|June 23, 2012
The mutational landscape of lethal castration-resistant prostate cancerCatherine S Grasso, Yi-Mi Wu, Dan R Robinson, et al.
Oncotarget|November 23, 2017
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategyDaniel H Hovelson, Chia-Jen Liu, Yugang Wang, et al.
Neoplasia (New York, N.Y.)|May 1, 2015
Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumorsDaniel H Hovelson, Andrew S McDaniel, Andi K Cani, et al.
Cancer Cell|September 11, 2020
Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S Grasso, Jennifer Tsoi, Mykola Onyshchenko, et al.
Pageof 4